The U.S. hospice market size was valued at USD 32.1 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 8.20% over the forecast period. The rising geriatric population coupled with the increasing prevalence of chronic as well as age-associated diseases is anticipated to boost the market growth. According to the Population Reference Bureau, the U.S. population aged 65 years and above is expected to reach 95 million by 2060 from 52 million in 2018. The high prevalence of cancer, dementia, and respiratory, cardiovascular, and kidney diseases among the geriatric population is projected to further drive the market growth.
The growing need for quality healthcare services at home along with the increasing Medicare reimbursement for hospice is expected to fuel the market growth over the forecast period. Medicare, Medicaid, and other public and private organizations provide coverage for hospice services. According to the Federal Register, the Centers for Medicare & Medicaid Services (CMS) proposed a 2.7% increase in the payment rate of hospice for FY 2020.The benefits of hospice services include comfort care by professionals and family, less financial burden or reduced out-of-pocket expenses, comprehensive care plans, and family counseling.
In addition, it also helps avoid unwanted procedures, medical treatments, and hospitalizations. In addition, the growing significance of targeted service is anticipated to boost market growth in the coming years. The growing importance oftelemedicineis also expected to drive the market. The technology is marking its presence to extend its care to outpatient settings to improve care coordination. The Hospice of Santa Cruz County is launching a telehealth program for palliative and hospice services that would enable medication management, virtual visits, and other services with the help of a grant it received from the Central California Alliance for Health.
Pandemic Impact |
Post COVID Outlook |
According to the NAHC survey in 2020, nearly two-thirds (61%) of hospices admitted COVID-19 positive patients in their care. At the same time, more than half of those polled said admissions were down in March 2020 compared to March 2019. More than a quarter of respondents experienced a 15% or greater decline in admissions |
Providers are experiencing a shift in their referral mix post-pandemic. As more patients and families prefer to avoid institutional care to limit the risk of infection, hospices are receiving fewer referrals from skilled nursing institutions and hospitals while those coming from primary medical practices are rising significantly |
Staffing costs and lower referrals were some of the major factors that contributed to higher expenditure/lost revenues. For instance, in 2020, LHC Group’s net service revenue decreased by ~1% compared to 2019, due to the impact of the COVID-19 pandemic. |
In the current scenario, hospices have substantially adopted the technology. In NAHC’s survey, more than 84% of respondents reported that they use telecommunications technology to deliver services to Medicare patients, with 82% saying they use two-way audiovisual communications, which has a positive impact on the overall market |
Hospice patients spend up to 9 fewer days in the hospital. Hospice is by far the least expensive patient environment, with an average daily per diem of approximately USD 190 (Routine Home Care [days 1–60] each day). Hospice and palliative care benefit the elderly by decreasing hospitalizations, focusing on the body, mind, & spirit, managing pain & symptoms, and supporting patients & families in comprehending treatment regimens, resulting in increased demand for these services.
On the basis of type, the market is segmented into Routine Home Care (RHC), Continuous Home Care (CHC), inpatient respite care, and general inpatient care. The RHC segment accounted for the largest revenue share of more than 90.0% in 2021. This can be attributed to factors, such as favorable reimbursement policies, increased comfort, and routine visits by registered nurses, physicians, and aides. It has the advantage of receiving companionship, family involvement, constant attention, and more. In 2020, VITAS Healthcare generated the maximum of its revenue from RHC. According to NHPCO, in 2018, 89.81% of the total Medicare spending was for RHC, an increase of 17.8% from 2014.
Other settings, such as inpatient respite care, CHC, and general inpatient homecare are anticipated to grow at a steady pace over the forecast period. Continuous home care is short-term services provided at home where symptoms cannot be managed. Furthermore, as the main aim of CHC is to manage acute symptom crises at home, it significantly reduces hospital admissions. A study published in NCBI found that hospice CHC decreases the likelihood of hospitalization and disenrollment. Thus, it provides comprehensive end-of-life care. These factors are expected to drive the segment growth.
On the other hand, inpatient homecare and inpatient respite care services are provided in healthcare facilities as the symptoms cannot be managed at home. The inpatient respite care segment is expected to grow significantly owing to supportive reimbursement policies for respite care and increasing focus on the mental health of primary care providers.
On the basis of location, the market is segmented into hospice centers, hospital, home hospice care, and skilled nursing facility. The hospice center segment held the maximum revenue share of more than 58.00% in 2021 owing to the benefits offered by these facilities. These centers prevent the need for hospitalization and offer more balanced and controlled care settings. Hospice centers can be helpful to patients who need round-the-clock care or do not have a caregiver. According to NHPCO, in 2018, 12.8% of the total Medicare hospice deaths occurred in hospice in-patient facilities.
The rising demand for respite care to give personal space to the primary caregiver is contributing to the segment growth. The home hospice care segment is anticipated to register significant growth during the forecast period l. The segment growth is credited to the rising preference by patients and families for home hospice care as it offers a more comfortable environment to the patient along with the freedom to visitors. In addition, it saves family members the traveling costs required to reach the patient. It is a more cost-effective option compared to long-term hospital stays.
The dementia segment dominated the market in 2021 with a revenue share of 25.3%. The segment is expected to grow further maintaining its dominant position during the forecasts period. Dementia is one of the leading causes of mental impairment and dependency among the elderly contributing to the growth of the segment. Individuals with end-stage dementia lose awareness, become vulnerable to infections, and have increased difficulty in communicating, which increases the need for effective treatment.Effective end-of-life care prevents and relieves suffering and supports patients in the best possible way. It also reduces the caregivers’ burden and ensures optimal treatment decisions.
The mortality rate due to Alzheimer’s disease is on the rise in the U.S., which ultimately increases the demand for palliative care. According to Alzheimer’s Association, in 2021, an estimated 6.2 million Americans aged 65 years and above will have Alzheimer’s dementia. Around 72% of those people are over the age of 75 years. The cancer segment is also expected to hold a considerable share of the global market by 2030 owing to the growing prevalence of cancer among the geriatric population. The rising preference for palliative care among the families of cancer patients is anticipated to fuel the growth of this segment. According to NHPCO, cancer is one of the largest categories for diagnoses, accounting for around 29.6% of patients. Patients with a principal diagnosis of cancer had 45.6 days of care on average, in 2018.
Key players are strengthening their position in the market through activities, such as partnerships, collaborations, mergers, and acquisitions. For instance, in April 2019, Geisinger Home Health and Hospice & LHC Group, Inc. entered into a joint venture to improve home health and hospice services in Pennsylvania. The partnership aims to offer hospice services in Danville, Wilkes-Barre, Bloomsburg, Lewisburg and Camp Hill, Northumberland, Lewistown, Montoursville, and Pennsylvania. Some of the prominent players in the U.S. hospice market include:
Kindred Healthcare Inc.
Amedisys
LHC Group, Inc.
Brookdale Senior Living, Inc.
Chemed Corp.
Crossroads Hospice
Seasons Hospice & Palliative Care
Accentcare, Inc.
Heart to Heart Hospice
Oklahoma Palliative & Hospice Care
Report Attribute |
Details |
Market size value in 2022 |
USD 34.5 billion |
Revenue forecast in 2030 |
USD 64.7 billion |
Growth rate |
CAGR of 8.20% from 2022 to 2030 |
Base year for estimation |
2021 |
Historical data |
2017 - 2020 |
Forecast period |
2022 - 2030 |
Quantitative units |
Revenue in USD billion and CAGR from 2022 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Location, type, diagnosis |
Country scope |
U.S. |
Key companies profiled |
Kindred Healthcare Inc.; Amedisys; LHC Group, Inc.; Brookdale Senior Living, Inc.; Chemed Corporation; Crossroads Hospice; Seasons Hospice & Palliative Care; Accentcare, Inc.; Heart to Heart Hospice and Oklahoma Palliative & Hospice Care |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope |
革命制度党cing and purchase options |
Avail customized purchase options to meet your exact research needs.Explore purchase options |
This report forecasts revenue growth at the country leveland provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For the purpose of this study, Grand View Research has segmented the U.S. hospice market report on the basis of location, type, and diagnosis:
TypeOutlook (Revenue, USD Billion, 2017 - 2030)
Routine Home Care
Continuous Home Care
Inpatient Respite Care
General Inpatient Care
Location Outlook (Revenue, USD Million, 2017 - 2030)
Hospice Center
Hospital
Home Hospice Care
Skilled Nursing Facility
Diagnosis Outlook (Revenue, USD Million, 2017 - 2030)
Dementia
Circulatory/Heart
Cancer
Respiratory
Stroke
Chronic Kidney Disease
Others
b.The U.S. hospice market size was estimated at USD 32.1 billion in 2021 and is expected to reach USD 34.5 billion in 2022.
b.The U.S. hospice market is expected to grow at a compound annual growth rate of 8.20% from 2022 to 2030 to reach USD 64.7 billion by 2030.
b.Routine home care dominated the U.S. hospice market with a share of 90.4% in 2021. This is attributable to favorable reimbursement policies; increased comfort; and routine visits by registered nurses, hospice physicians, and hospice aide.
b.Some key players operating in the U.S. hospice market include Kindred Healthcare, Inc.; Chemed Corporation; Amedisys; LHC Group, Inc.; Brookdale Senior Living Solutions; Seasons Hospice & Palliative Care; Crossroads Hospice; AccentCare; Heart to Heart Hospice; and Oklahoma Palliative & Hospice Care.
b.Key factors that are driving the U.S. hospice market growth are the increasing number of hospice centers, the rising elderly population, and the increasing prevalence of chronic as well as age-associated diseases.
b.Hospice center dominated the U.S. hospice market with a share of 58.2% in 2021. This is attributable to the increasing demand for hospice centers and strategies adopted by key players to expand their geographical footprints.
b.Dementia dominated the U.S. hospice market with a share of 25.3% in 2021. This is attributable to the rising prevalence of Alzheimer's disease and increasing geriatric population.
“他们为我们所做的研究的质量been excellent."